The Future of Analytical and Interpretative Toxicology: Where are We Going and How Do We Get There?

被引:4
|
作者
Wille, Sarah M. R. [1 ]
Elliott, Simon [2 ,3 ]
机构
[1] Natl Inst Criminalist & Criminol, Dept Toxicol, Brussels, Belgium
[2] Elliott Forens Consulting Ltd, Birmingham, W Midlands, England
[3] Kings Coll London, Dept Analyt Environm & Forens Sci, London, England
关键词
DEPENDENT POSTMORTEM REDISTRIBUTION; ALTERNATIVE MATRICES; DRUG-INTERACTIONS; PSYCHOACTIVE SUBSTANCES; ACUTE INTOXICATION; POTENTIAL MARKERS; OPIOID WITHDRAWAL; BAYESIAN NETWORK; BLOOD-SAMPLES; PHARMACOGENETICS;
D O I
10.1093/jat/bkaa133
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
(Forensic) toxicology has faced many challenges, both analytically and interpretatively, especially in relation to an increase in potential drugs of interest. Analytical toxicology and its application to medicine and forensic science have progressed rapidly within the past centuries. Technological innovations have enabled detection of more substances with increasing sensitivity in a variety of matrices. Our understanding of the effects (both intended and unintended) have also increased along with determination and degree of toxicity. However, it is clear there is even more to understand and consider. The analytical focus has been on typical matrices such as blood and urine but other matrices could further increase our understanding, especially in postmortem (PM) situations. Within this context, the role of PM changes and potential redistribution of drugs requires further research and identification of markers of its occurrence and extent. Whilst instrumentation has improved, in the future, nanotechnology may play a role in selective and sensitive analysis as well as bioassays. Toxicologists often only have an advisory impact on pre-analytical and pre-interpretative considerations. The collection of appropriate samples at the right time in an appropriate way as well as obtaining sufficient circumstance background is paramount in ensuring an effective analytical strategy to provide useful results that can be interpreted within context. Nevertheless, key interpretative considerations such as pharmacogenomics and drug-drug interactions as well as determination of tolerance remain and in the future, analytical confirmation of an individual's metabolic profile may support a personalized medicine and judicial approach. This should be supported by the compilation and appropriate application of drug data pursuant to the situation. Specifically, in PM circumstances, data pertaining to where a drug was not/may have been/was contributory will be beneficial with associated pathological considerations. This article describes the challenges faced within toxicology and discusses progress to a future where they are being addressed.
引用
收藏
页码:619 / 632
页数:14
相关论文
共 50 条
  • [31] ICT in ELT: how did we get here and where are we going?
    Dudeney, Gavin
    Hockly, Nicky
    ELT JOURNAL, 2012, 66 (04) : 533 - 542
  • [32] Place marketing: how did we get here and where are we going?
    Kavaratzis, Mihalis
    Ashworth, Gregory
    JOURNAL OF PLACE MANAGEMENT AND DEVELOPMENT, 2008, 1 (02) : 150 - 165
  • [33] CLOSING THE LOOP - HOW DID WE GET HERE AND WHERE ARE WE GOING
    REID, MT
    LIBRARY RESOURCES & TECHNICAL SERVICES, 1995, 39 (03): : 267 - 273
  • [34] Patient-centered Radiology: Where Are We, Where Do We Want to Be, and How Do We Get There?
    Kemp, Jennifer L.
    Mahoney, Mary C.
    Mathews, Vincent P.
    Wintermark, Max
    Yee, Judy
    Brown, Stephen D.
    RADIOLOGY, 2017, 285 (02) : 601 - 608
  • [35] The Expanded Core Curriculum: Where We Have Been, Where We Are Going, and How We Can Get There
    Sapp, Wendy
    Hatlen, Phil
    JOURNAL OF VISUAL IMPAIRMENT & BLINDNESS, 2010, 104 (06) : 338 - 348
  • [36] Brexit, nationalism, populism: Where are we now? How did we get here? Where are we going?
    Phillips, Adam
    Barwick, Nick
    PSYCHODYNAMIC PRACTICE, 2020, 26 (02) : 106 - 123
  • [37] How did we get here and where do we go?
    Oakley, F
    Russett, B
    GOVERNANCE, ACCOUNTABILITY, AND THE FUTURE OF THE CATHOLIC CHURCH, 2004, : 7 - 12
  • [38] The DO upgrade: where we are and where we are going
    Evans, HG
    NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2001, 462 (1-2): : 179 - 183
  • [39] What Do We Do and Where Are We Going?
    Sanchez, Andrew
    CAMBRIDGE JOURNAL OF ANTHROPOLOGY, 2018, 36 (02): : V - VI
  • [40] How do we know where things are going?
    Badcock, DR
    McKendrick, AM
    Wyatt, AM
    AUSTRALIAN JOURNAL OF PSYCHOLOGY, 2002, 54 (01) : 48 - 48